KLEA HOLDING (ALKLH.PA) Stock Fundamental Analysis
EPA:ALKLH - Euronext Paris - Matif - FR0013481835 - Common Stock - Currency: EUR
Overall ALKLH gets a fundamental rating of 5 out of 10. We evaluated ALKLH against 59 industry peers in the Health Care Equipment & Supplies industry. ALKLH has only an average score on both its financial health and profitability. ALKLH shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
ALKLH had negative earnings in the past year.
ALKLH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALKLH reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ALKLH reported negative operating cash flow in multiple years.
1.2 Ratios
ALKLH has a better Return On Assets (3.71%) than 62.71% of its industry peers.
With a Return On Equity value of 5.03%, ALKLH perfoms like the industry average, outperforming 47.46% of the companies in the same industry.
With a Return On Invested Capital value of 4.21%, ALKLH perfoms like the industry average, outperforming 49.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.71% | ||
| ROE | 5.03% | ||
| ROIC | 4.21% |
ROA(3y)-2.81%
ROA(5y)-21.14%
ROE(3y)-4.32%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 8.14%, ALKLH is doing good in the industry, outperforming 61.02% of the companies in the same industry.
ALKLH has a Operating Margin (9.65%) which is in line with its industry peers.
The Gross Margin of ALKLH (95.14%) is better than 94.92% of its industry peers.
ALKLH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.65% | ||
| PM (TTM) | 8.14% | ||
| GM | 95.14% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.3%
GM growth 5Y22.31%
2. Health
2.1 Basic Checks
ALKLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALKLH has more shares outstanding
Compared to 5 years ago, ALKLH has more shares outstanding
The debt/assets ratio for ALKLH has been reduced compared to a year ago.
2.2 Solvency
ALKLH has an Altman-Z score of 3.60. This indicates that ALKLH is financially healthy and has little risk of bankruptcy at the moment.
ALKLH has a better Altman-Z score (3.60) than 64.41% of its industry peers.
The Debt to FCF ratio of ALKLH is 34.84, which is on the high side as it means it would take ALKLH, 34.84 years of fcf income to pay off all of its debts.
ALKLH has a Debt to FCF ratio (34.84) which is in line with its industry peers.
ALKLH has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
ALKLH has a Debt to Equity ratio of 0.15. This is in the better half of the industry: ALKLH outperforms 76.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 34.84 | ||
| Altman-Z | 3.6 |
ROIC/WACC0.56
WACC7.52%
2.3 Liquidity
ALKLH has a Current Ratio of 1.35. This is a normal value and indicates that ALKLH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.35, ALKLH is in line with its industry, outperforming 40.68% of the companies in the same industry.
A Quick Ratio of 1.35 indicates that ALKLH should not have too much problems paying its short term obligations.
The Quick ratio of ALKLH (1.35) is better than 66.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
ALKLH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 260.87%, which is quite impressive.
The Revenue has grown by 25.93% in the past year. This is a very strong growth!
Measured over the past years, ALKLH shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)260.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)25.93%
Revenue growth 3Y34%
Revenue growth 5Y11.01%
Sales Q2Q%28.36%
3.2 Future
ALKLH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
The Revenue is expected to grow by 24.27% on average over the next years. This is a very strong growth
EPS Next Y0%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.18%
Revenue Next 2Y24.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Forward Earnings ratio of 17.55, ALKLH is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALKLH indicates a somewhat cheap valuation: ALKLH is cheaper than 69.49% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ALKLH to the average of the S&P500 Index (22.19), we can say ALKLH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 17.55 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALKLH.
ALKLH's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 334.93 | ||
| EV/EBITDA | 28.06 |
4.3 Compensation for Growth
A more expensive valuation may be justified as ALKLH's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ALKLH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALKLH (6/18/2025, 7:00:00 PM)
0.1808
0 (-0.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.60M
Analysts86.67
Price Target0.51 (182.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 17.55 | ||
| P/S | 3.22 | ||
| P/FCF | 334.93 | ||
| P/OCF | 59.65 | ||
| P/B | 1.99 | ||
| P/tB | 19.76 | ||
| EV/EBITDA | 28.06 |
EPS(TTM)0
EYN/A
EPS(NY)0.01
Fwd EY5.7%
FCF(TTM)0
FCFY0.3%
OCF(TTM)0
OCFY1.68%
SpS0.06
BVpS0.09
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.71% | ||
| ROE | 5.03% | ||
| ROCE | 5.12% | ||
| ROIC | 4.21% | ||
| ROICexc | 4.68% | ||
| ROICexgc | 33.31% | ||
| OM | 9.65% | ||
| PM (TTM) | 8.14% | ||
| GM | 95.14% | ||
| FCFM | 0.96% |
ROA(3y)-2.81%
ROA(5y)-21.14%
ROE(3y)-4.32%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.3%
GM growth 5Y22.31%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 34.84 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 189.6% | ||
| Cap/Sales | 4.44% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 45.02% | ||
| Profit Quality | 11.81% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 3.6 |
F-Score6
WACC7.52%
ROIC/WACC0.56
Cap/Depr(3y)158.1%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.55%
Cap/Sales(5y)13.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y0%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.93%
Revenue growth 3Y34%
Revenue growth 5Y11.01%
Sales Q2Q%28.36%
Revenue Next Year34.18%
Revenue Next 2Y24.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y618.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year310%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.11%
OCF growth 3YN/A
OCF growth 5YN/A